PRINCETON, N.J.--(BUSINESS WIRE)--June 13, 2006--PhytoMedical Technologies, Inc. (OTCBB:PYTO - News; FWB:ET6), through its wholly owned subsidiary, today announced that it has entered into an exclusive license agreement with Iowa State University Research Foundation Inc. (ISURF) to develop, market and distribute novel synthesized compounds derived from type A-1 polyphenols, which have been linked to insulin sensitivity by lead researcher, Dr. Richard Anderson of the USDA's Agricultural Research Service.
